10x Genomics Reports Second Quarter 2026 Financial Results

<p>PLEASANTON, Calif., Aug. 6, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today reported financial results for the second quarter ended June 30, 2026. Recent Updates Revenue was $151.0...</p>